Meisel JD, Joshi PR, Spelbring AN, et al. Mutations in mitochondrial ferredoxin FDX2 suppress frataxin deficiency. Nature. 2025. doi:10.1038/s41586-025-09821-2
Publications
Grotzinger AD, Werme J, Peyrot WJ, et al. Mapping the genetic landscape across 14 psychiatric disorders. Nature. 2025. doi:10.1038/s41586-025-09820-3
Aliee H, Bejarano-Bosque L, Castells-Graells R, et al. The 2025 generation. Nature cancer. 2025. doi:10.1038/s43018-025-01086-y
Pacheco MP, Gerard D, Mangan RJ, et al. Epigenetic control of metabolic identity across cell types. BMC genomics. 2025. doi:10.1186/s12864-025-12155-y
Wang S, Li T, Naish M, et al. CDCA7 facilitates MET1-mediated CG DNA methylation maintenance in centromeric heterochromatin via linker histone H1. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(50):e2526408122. doi:10.1073/pnas.2526408122
Kurganov E, Cui L, Budnik N, et al. Characterization of the functional and clinical impacts of missense variants found in neurodevelopmental disorders. Science translational medicine. 2025;17(828):eadr0024. doi:10.1126/scitranslmed.adr0024
Tamura S, Nelson AD, Spratt PWE, et al. Publisher Correction: CRISPR activation for SCN2A-related neurodevelopmental disorders. Nature. 2025. doi:10.1038/s41586-025-09995-9
Wang S. Extracellular vesicle delivery of myristoylated Cas9 highlights chromatin accessibility as an efficacy barrier in prostate cancer. Molecular therapy : the journal of the American Society of Gene Therapy. 2025. doi:10.1016/j.ymthe.2025.11.037
Wang M, Li W, Hao J, et al. Biomaterial-minimalistic photoactivated bioprinting of cell-dense tissues. Cell. 2025. doi:10.1016/j.cell.2025.11.012
Mody AC, Ramirez DH, Woo CM. Targeted protein O-GlcNAc reveals transcriptional functions for O-GlcNAc. Cell chemical biology. 2025. doi:10.1016/j.chembiol.2025.11.003